Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Optimi Health ( (TSE:OPTI) ) just unveiled an update.
Optimi Health Corp. is set to finalize a non-brokered private placement, issuing 131,666 units to raise CAD$395,000, with insiders participating. The proceeds will be used for general working capital and the offering involves a related party transaction. Additionally, Optimi is settling a CAD$98,126.25 debt with two creditors by issuing common shares, with both transactions expected to close by January 24, 2025.
More about Optimi Health
Optimi Health Corp. is a Health Canada-licensed, GMP-compliant manufacturer specializing in natural psilocybin and MDMA. The company focuses on producing high-quality psychedelic products to support global mental health therapies through compliance, innovation, and collaboration.
YTD Price Performance: 7.14%
Average Trading Volume: 72,763
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$21.3M
For detailed information about OPTI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money